Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Alhassan Kallon
Observed name:
A Kallon
Institutions:
London School of Hygiene & Tropical Medicine,
Mwanza Intervention Trials Unit,
National Institute for Medical Research
Observed institutions:
London School of Hygiene & Tropical Medicine,
Mwanza Intervention Trials Unit,
National Institute for Medical Research
ORCID:
0009-0003-3470-9819
Observed ORCID:
0009-0003-3470-9819
OpenAlex ID:
A5040693092
Safety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trial
2021
·
David Ishola
, Daniela Manno
, et al.
·
The Lancet Infectious Diseases
·
105
PDF
Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial
2021
·
Muhammed O Afolabi
, David Ishola
, et al.
·
The Lancet Infectious Diseases
·
102
PDF
Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in infants: a phase 2, randomised, double-blind, active-controlled trial in Guinea and Sierra Leone
2023
·
Edward Man-Lik Choi
, Boris Lacarra
, et al.
·
The Lancet Global Health
·
20
PDF
An Empirical Assessment of Exchange Rate Depreciation and Currency Substitution in Sierra Leone
2023
·
Alhassan Kallon
, Alhaji Sorie Ibrahim Barrie
·
Modern Economy
·
3
PDF
An Empirical Analysis of the Monetary Policy Transmission Channels in Sierra Leone
2024
·
Alhassan Kallon
·
Economic Insights – Trends and Challenges
·
2
PDF
Show more works
View as search
Works count:
5
Citation count:
232
H-index:
3
I10-index:
3
Year
Topic
Type